Verastem (VSTM) Accounts Payables (2011 - 2026)
Verastem's (VSTM) quarterly Accounts Payables came in at $9.6 million in Q1 2026, up 33.38% year-on-year from $7.2 million in Q1 2025, and down 22.86% quarter-over-quarter from $12.4 million in Q4 2025.
Verastem (VSTM) Accounts Payables (2011 - 2026) Analysis & Trends
Verastem's Accounts Payables history runs 16 years deep, the most recent figure standing at $9.6 million for Q1 2026.
- On a quarterly basis, Accounts Payables rose 33.38% year-over-year to $9.6 million in Q1 2026; TTM through Mar 2026 was $9.6 million, a 33.38% increase from a year earlier, with the FY2025 full-year figure at $12.4 million, up 209.19% from the prior year.
- Accounts Payables slipped to $9.6 million in Q1 2026 per VSTM's latest filing, from $12.4 million in the prior quarter.
- Across five years, Accounts Payables topped out at $12.4 million in Q4 2025 and bottomed at $1.7 million in Q2 2022.
- The 5-year median for Accounts Payables is $5.4 million (2022), against an average of $6.3 million.
- Across the five-year window, Accounts Payables surged 736.04% in 2022 and plunged 43.96% in 2024, its largest moves.
- Year by year, Accounts Payables stood at $4.9 million in 2022, then jumped by 46.58% to $7.2 million in 2023, then plunged by 43.96% to $4.0 million in 2024, then surged by 209.19% to $12.4 million in 2025, then declined by 22.86% to $9.6 million in 2026.
- Per Business Quant, the three latest VSTM Accounts Payables figures stand at $9.6 million (Q1 2026), $12.4 million (Q4 2025), and $9.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | 9.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.60 Mn |
| Dec 31, 2025 | 12.45 Mn |
| Sep 30, 2025 | 9.89 Mn |
| Jun 30, 2025 | 8.05 Mn |
| Mar 31, 2025 | 7.20 Mn |
| Dec 31, 2024 | 4.03 Mn |
| Sep 30, 2024 | 4.44 Mn |
| Jun 30, 2024 | 6.68 Mn |
| Mar 31, 2024 | 7.45 Mn |
| Dec 31, 2023 | 7.18 Mn |
| Sep 30, 2023 | 5.12 Mn |
| Jun 30, 2023 | 4.55 Mn |
| Mar 31, 2023 | 4.90 Mn |
| Dec 31, 2022 | 4.90 Mn |
| Sep 30, 2022 | 5.36 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 2.90 Mn |
| Dec 31, 2021 | 2.30 Mn |
| Sep 30, 2021 | 641,000.00 |
| Jun 30, 2021 | 1.40 Mn |